3P Consulting was founded in 1998 by a group of specialists in pharmaceutical medicine or clinical pharmacology who have held senior positions in industry (Medical Directors) and/or academia.
3P Consulting provides consulting and clinical development services to pharmaceutical companies and research organisations (including universities).
Our three main areas of expertise are:
All senior staff members of 3P Consulting are medical doctors, and all members of the consulting staff are MDs and/or PhDs. Several have teaching or consulting commitments at major medical faculties.
Together we have published more than 400 original papers, abstracts in peer-reviewed journals or have contributed to books. In addition, we have run a significant number of large-scale medical and medico-marketing projects.
Our senior staff members are on the steering boards of major clinical or epidemiological studies, or on the editorial boards of renowned scientific journals.
3P Consulting advises leading international companies, as well as distinguished biotech and specialized firms.
We also consult on large-scale university-driven research projects. For example, recent studies include NISAS (sleep disorders, 20 000 patients), HYDRA (hypertension and diabetes, 45000 patients), DETECT (cardiovascular risk, 55000 patients) and getABI (peripheral arterial disease, 6880 patients).